Global $22+ Billion Ocular Implants (Glaucoma Implants, Intraocular Lens) Markets to 2030: Increasing Focus on the Development of Technologically Advanced Products is Expected to Drive the Market
March 18, 2022 05:03 ET
|
Research and Markets
Dublin, March 18, 2022 (GLOBE NEWSWIRE) -- The "Ocular Implants Market Size, Share & Trends Analysis Report by Product (Glaucoma Implants, Intraocular Lens), by Application (Glaucoma Surgery,...
Graybug Vision Reports Full Year 2021 Financial Results and Recent Corporate Developments
March 10, 2022 07:30 ET
|
Graybug Vision, Inc.
BALTIMORE, March 10, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of...
Global Bionic Eye Market Research Report 2021 Featuring Nidek, Nano Retina, MetaModa, Pixium Vision, Monash Vision, iBionics & Optobionics
March 10, 2022 04:03 ET
|
Research and Markets
Dublin, March 10, 2022 (GLOBE NEWSWIRE) -- The "Global Bionic Eye Market, By Type (Implant v/s External), By Technology (Electronic v/s Mechanical), By End User (Hospitals, Ophthalmic Clinics,...
ONL Therapeutics Appoints Sushanta Mallick as Chief Development Officer
February 09, 2022 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 09, 2022 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Graybug to Participate in Three Upcoming Medical and Investor Conferences
February 03, 2022 07:30 ET
|
Graybug Vision, Inc.
BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of...
Graybug Vision Makes Key Hires to Further Build Momentum Behind its Pipeline
January 20, 2022 07:30 ET
|
Graybug Vision, Inc.
BALTIMORE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of...
Worldwide Ophthalmology Industry to 2027 - Surge in Research and Development to Provide New Treatment Presents Opportunities
January 18, 2022 05:08 ET
|
Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "Ophthalmology Market Research Report by Diseases, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been...
Global Automated Visual Field Analyzer Market Research Report (2021 to 2027) - by Product Type, End-use and Region
January 18, 2022 05:03 ET
|
Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "Automated Visual Field Analyzer Market Research Report by Product Type, by End-use, by Region - Global Forecast to 2027 - Cumulative Impact of...
Insights on the Pharma Ophthalmic Global Market to 2026 - Featuring Roche, Santen and Senju Among Others
December 16, 2021 09:48 ET
|
Research and Markets
Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Pharma Ophthalmic Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report...
iSTAR Medical receives European market approval for glaucoma implant MINIject
November 17, 2021 07:00 ET
|
iSTAR Medical
iSTAR Medical receives European market approval for glaucoma implant MINIject The only commercially available, minimally invasive supraciliary device for glaucoma now approved First commercial...